Literature DB >> 15014714

Using Atypical Antipsychotics in Primary Care.

.   

Abstract

Year:  2002        PMID： 15014714      PMCID： PMC315493     

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  34 in total

1.  Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

Authors:  I R Katz; D V Jeste; J E Mintzer; C Clyde; J Napolitano; M Brecher
Journal:  J Clin Psychiatry       Date:  1999-02       Impact factor: 4.384

2.  Quetiapine alone and added to a mood stabilizer for serious mood disorders.

Authors:  M Sajatovic; D W Brescan; D E Perez; S K DiGiovanni; H Hattab; J B Ray; C R Bingham
Journal:  J Clin Psychiatry       Date:  2001-09       Impact factor: 4.384

3.  Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study.

Authors:  M Atmaca; M Kuloglu; E Tezcan; O Gecici
Journal:  Int Clin Psychopharmacol       Date:  2002-05       Impact factor: 1.659

4.  Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.

Authors:  M Tohen; T G Jacobs; S L Grundy; S L McElroy; M C Banov; P G Janicak; T Sanger; R Risser; F Zhang; V Toma; J Francis; G D Tollefson; A Breier
Journal:  Arch Gen Psychiatry       Date:  2000-09

5.  Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.

Authors:  M Tohen; T M Sanger; S L McElroy; G D Tollefson; K N Chengappa; D G Daniel; F Petty; F Centorrino; R Wang; S L Grundy; M G Greaney; T G Jacobs; S R David; V Toma
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

6.  Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.

Authors:  G Francobandiera
Journal:  Can J Psychiatry       Date:  2001-05       Impact factor: 4.356

7.  Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.

Authors:  J S Street; W S Clark; K S Gannon; J L Cummings; F P Bymaster; R N Tamura; S J Mitan; D L Kadam; T M Sanger; P D Feldman; G D Tollefson; A Breier
Journal:  Arch Gen Psychiatry       Date:  2000-10

8.  A double-blind pilot study of risperidone in the treatment of conduct disorder.

Authors:  R L Findling; N K McNamara; L A Branicky; M D Schluchter; E Lemon; J L Blumer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-04       Impact factor: 8.829

9.  Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.

Authors:  Gary S Sachs; Fred Grossman; S Nassir Ghaemi; Akiko Okamoto; Charles L Bowden
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

10.  Prospective study of tardive dyskinesia in the elderly: rates and risk factors.

Authors:  M G Woerner; J M Alvir; B L Saltz; J A Lieberman; J M Kane
Journal:  Am J Psychiatry       Date:  1998-11       Impact factor: 18.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.